BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Xenova Group PLC  

957 Buckingham Avenue

Slough  Berkshire  SL1 4NL  United Kingdom
Phone: 01753-706-600 Fax: 01753-706-607


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Xenova Group PLC (XNVA) Grants Licence To PharmaEngine, Inc.10/19/2005 5:13:16 PM
Xenova Group PLC (XNVA) -- Preliminary Results For The Year Ended 31 December 200410/19/2005 5:12:54 PM
Xenova Group PLC (XNVA): Anti-Smoking Vaccine TA-NIC Preliminary 12 Month Clinical Trial Results10/19/2005 5:12:54 PM
Xenova Group PLC (XNVA): Preliminary Results For The Year Ended 31 December 200310/19/2005 5:12:51 PM
Xenova Group PLC (XNVA) -- TransMID Obtains Orphan Drug Designation In Japan10/19/2005 5:12:42 PM
The Week In Review: Another Slide For Biotech10/19/2005 5:12:20 PM
Xenova Group PLC (XNVA) Licenses DISC-HSV And DISC-GM-CSF Vector Technologies To Oxxon Therapeutics Inc.; $83 Million; Stock Up10/19/2005 5:12:16 PM
Xenova Group PLC (XNVA) Program Update; Millennium Pharmaceuticals, Inc. (MLNM) Has Decided To Cease Funding The XR5944/XR11576 Program After Completion Of The On-Going Phase I Studies10/19/2005 5:12:13 PM
Xenova Group PLC (XNVA) Licenses TA-CIN To Cancer Research Technology10/19/2005 5:12:07 PM
Xenova Group PLC (XNVA) And FDA Reach Agreement On SPA Phase III Trial Programme For TransMID -- Enrollment To Begin Immediately10/19/2005 5:11:15 PM
12